Antibody data
- Antibody Data
- Antigen structure
- References [3]
- Comments [0]
- Validations
- Western blot [1]
- Immunohistochemistry [1]
- Flow cytometry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN950412 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Angiopoietin 2 (ANGPT2) (AA 409-440), (C-Term) antibody
- Antibody type
- Polyclonal
- Description
- Affinity chromatography on Protein A
- Reactivity
- Human
- Host
- Rabbit
- Epitope
- AA 409-440, C-Term
- Vial size
- 0.4 mL
- Storage
- Store the antibody undiluted at 2-8°C for one month or (in aliquots) at -20°C for longer.
- Handling
- Avoid repeated freezing and thawing.
Submitted references Promoter variant of angiopoietin-2 and plasma angiopoietin-2 are associated with risk of stroke recurrence in lacunar infarct patients.
Inhibition of angiopoietin-2 in LuCaP 23.1 prostate cancer tumors decreases tumor growth and viability.
Angiopoietin-2 mRNA expression is increased in chronic lymphocytic leukemia patients with poor prognostic features.
Chen J, Yu H, Sun K, Song W, Bai Y, Yang T, Song Y, Zhang Y, Hui R
Biochemical and biophysical research communications 2010 Jul 23;398(2):212-6
Biochemical and biophysical research communications 2010 Jul 23;398(2):212-6
Inhibition of angiopoietin-2 in LuCaP 23.1 prostate cancer tumors decreases tumor growth and viability.
Morrissey C, Dowell A, Koreckij TD, Nguyen H, Lakely B, Fanslow WC, True LD, Corey E, Vessella RL
The Prostate 2010 Dec 1;70(16):1799-808
The Prostate 2010 Dec 1;70(16):1799-808
Angiopoietin-2 mRNA expression is increased in chronic lymphocytic leukemia patients with poor prognostic features.
Vrbacky F, Smolej L, Vroblova V, Pekova S, Hrudkova M, Cervinka M, Pecka M, Krejsek J, Maly J
Hematology (Amsterdam, Netherlands) 2010 Aug;15(4):210-4
Hematology (Amsterdam, Netherlands) 2010 Aug;15(4):210-4
No comments: Submit comment
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- IHC
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- FACS